GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT05216042
- Status
- Recruiting
Conditions
- Cardiometabolic Diseases
- Cardiovascular Diseases
- Energy Expenditure
- Exercise
- Glucose Metabolism
- Natriuretic Peptides
- Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Study diet — DIETARY_SUPPLEMENTParticipants will consume the study diet for 5 days provided by the clinical research unit's metabolic kitchen (at UAB)
- Exercise capacity VO2 max determination — OTHEREach participant's maximal oxygen capacity will be determined using a modified Bruce treadmill protocol and will also undergo a DEXA scan to determine the body mass.
- Exercise Challenge — OTHEREach participant will walk at 70 % of his/her VO2max for 20 minutes on treadmill and will also undergo a resting energy expenditure test.
- Glucose Challenge — OTHERParticipants will come in fasting state on day 6th and will be given 75 gm oral glucose solution to drink, followed by blood collection every hour for next 8 hours.
Study Details
Natriuretic Peptides (NP) are hormones produced by the heart, and they have a wide range of favorable metabolic benefits. Lower levels of these hormones are associated with an increased likelihood of the development of diabetes and poor cardiometabolic health. Obese and Black individuals have \~30% lower levels of NP and are at a greater risk of developing cardiovascular (CV) events as compared to lean and White counterparts. Some people have common genetic variations that cause them to have \~20% lower NP levels. Similar to other low NP populations, these individuals with low NP genotype (i.e., carrying a common genetic variation called rs5068) are at a greater risk of developing cardiometabolic diseases. By understanding the NP response following the exercise challenge and the glucose challenge in individuals with genetically lower NP levels will help us understand how to improve cardiometabolic health in them.
Key Dates
- Start date
- Apr 1, 2022
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2026
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Experimental: Low NP Genotype Group150 healthy adult participants with low NP genotype will be enrolled and each will undergo a physical exam and screening tests to determine participants' eligibility. Participants will consume the study diet for 5 days. On 5th day, the participants will come in for an exercise challenge test. On 6th day, participants will come in a fasting state and drink 75 gm of oral glucose, followed by blood collection every 8 hours.
- Experimental: Active Comparator: High NP Genotype Group50 healthy adult participants with high NP genotype will be enrolled and each will undergo a physical exam and screening tests to determine participants' eligibility. Participants will consume the study diet for 5 days. On 5th day, the participants will come in for an exercise challenge test. On 6th day, participants will come in a fasting state and drink 75 gm of oral glucose, followed by blood collection every 8 hours.
Primary Outcome Measure
Change in MRproANP levels following a standardized oral glucose challenge between the high genotype group and low genotype group. [ Time Frame: From 1st hour to 8th hour on the main study visit day after consuming study meals for 5 days ]
Central Contacts
- Nehal Vekariya, MS205-934-7173
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | Pankaj Arora, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
Related Studies
- NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black IndividualsPHASE2 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- International Weight Control RegistryRecruiting · Tufts University · Birmingham, Alabama
- PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm AxisPHASE2/PHASE3 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama